Katelyn Sellgren

Katelyn Sellgren is a highly skilled scientist with extensive experience in developing fecal-based diagnostic tools and conducting research in tissue engineering and biomedical applications. Currently serving as a Scientist II at Novonesis since November 2020, Katelyn previously worked at Duke University as a Research Scientist focused on health evaluation technologies and regulatory compliance through IRB protocols. Katelyn's background includes significant roles at RTI International, where contributions involved electrochemical systems and microfluidic models, as well as postdoctoral research at Florida State University emphasizing osteogenic differentiation and cellular assays. Katelyn holds a PhD in Tissue Engineering and a Bachelor's degree in Chemical and Biomedical Engineering from Florida State University.